Can a popular weight-loss drug reduce risk of Alzheimer’s? Sub : Sci Sec :Human health Context: Recent research indicates that semaglutide, an active ingredient in diabetes and weight loss drugs such as Ozempic and Wegovy, may significantly reduce the risk of developing Alzheimer’s disease (AD) in individuals with type 2 diabetes. This finding […]